IDH1-mutant cancer cells are sensitive to cisplatin and an IDH1-mutant inhibitor counteracts this sensitivity

被引：0
|
作者：
Khurshed, Mohammed
Aarnoudse, Niels
Hulsbos, Renske
Hira, Vashendriya V. V.
van Laarhoven, Hanneke W. M.
Wilmink, Johanna W.
Molenaar, Remco J.
van Noorden, Cornelis J.
机构：
来源：
FASEB JOURNAL | 2019年 / 33卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
250.8
引用
收藏
页数：5
相关论文
共 50 条
  • [1] IDH1-mutant cancer cells are sensitive to cisplatin and an IDH1-mutant inhibitor counteracts this sensitivity
    Khurshed, Mohammed
    Aarnoudse, Niels
    Hulsbos, Renske
    Hira, Vashendriya V. V.
    van Laarhoven, Hanneke W. M.
    Wilmink, Johanna W.
    Molenaar, Remco J.
    van Noorden, Cornelis J. F.
    FASEB JOURNAL, 2018, 32 (11): : 6344 - 6352
  • [2] IDH1-mutated cancer cells are sensitive to cisplatin and an IDH1-mutant inhibitor counteracts this sensitivity
    Khurshed, Mohammed
    Molenaar, Remco J.
    Wilmink, Johanna W.
    van Laarhoven, Hanneke W.
    van Noorden, Cornelis J.
    CANCER RESEARCH, 2018, 78 (13)
  • [3] Ivosidenib for IDH1-mutant cholangiocarcinoma
    Baker, Holly
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2020, 5 (07): : 647 - 647
  • [4] Radioprotection of IDH1-Mutated Cancer Cells by the IDH1-Mutant Inhibitor AGI-5198
    Molenaar, Remco J.
    Botman, Dennis
    Smits, Myrthe A.
    Hira, Vashendriya V.
    van Lith, Sanne A.
    Stap, Jan
    Henneman, Peter
    Khurshed, Mohammed
    Lenting, Krissie
    Mul, Adri N.
    Dimitrakopoulou, Dionysia
    van Drunen, Cornelis M.
    Hoebe, Ron A.
    Radivoyevitch, Tomas
    Wilmink, Johanna W.
    Maciejewski, Jaroslaw P.
    Vandertop, W. Peter
    Leenders, William P.
    Bleeker, Fonnet E.
    van Noorden, Cornelis J.
    CANCER RESEARCH, 2015, 75 (22) : 4790 - 4802
  • [5] Ivosidenib effective in IDH1-mutant AML
    Peter Sidaway
    Nature Reviews Clinical Oncology, 2018, 15 : 472 - 472
  • [6] Ivosidenib for advanced IDH1-mutant cholangiocarcinoma
    Gervaso, Lorenzo
    Pellicori, Stefania
    Fazio, Nicola
    LANCET ONCOLOGY, 2020, 21 (08): : E370 - E370
  • [7] Spikes induced by IDH1-mutant gliomas
    Abounader, Roger
    Wright, Karen
    Bhat, Krishna
    Chamberlain, Marc
    Purow, Benjamin
    Soffietti, Riccardo
    NEURO-ONCOLOGY, 2017, 19 (10) : 1295 - 1296
  • [8] Ivosidenib effective in IDH1-mutant AML
    Sidaway, Peter
    NATURE REVIEWS CLINICAL ONCOLOGY, 2018, 15 (08) : 472 - 472
  • [9] An evaluation of ivosidenib for the treatment of IDH1-mutant cholangiocarcinoma
    Tella, Sri Harsha
    Mahipal, Amit
    EXPERT OPINION ON PHARMACOTHERAPY, 2022, 23 (17) : 1879 - 1885
  • [10] Clinical and Molecular Profile of IDH1-Mutant Cutaneous Melanoma
    Ross, J. S.
    Elvin, J. A.
    Sokol, E. S.
    Shah, N.
    Miller, V. A.
    Tse, J. Y.
    Williams, E. A.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2019, 21 (06): : 1122 - 1122
12345